These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27249851)

  • 41. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
    Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
    J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital anomalies in a child born from a mother with interferon-treated chronic hepatitis B.
    Watanabe M; Kohge N; Akagi S; Uchida Y; Sato S; Kinoshita Y
    Am J Gastroenterol; 2001 May; 96(5):1668-9. PubMed ID: 11374741
    [No Abstract]   [Full Text] [Related]  

  • 43. Update on viral hepatitis in pregnancy.
    Shao Z; Al Tibi M; Wakim-Fleming J
    Cleve Clin J Med; 2017 Mar; 84(3):202-206. PubMed ID: 28322675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interdisciplinary aspects of and new drugs for chronic hepatitis B].
    Horváth G
    Orv Hetil; 2013 Jul; 154(29):1142-50. PubMed ID: 23853347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Women diagnosed with chronic hepatitis B.
    Cabrié T
    Aust Nurs Midwifery J; 2015 Apr; 22(9):50. PubMed ID: 26449070
    [No Abstract]   [Full Text] [Related]  

  • 46. Approach to chronic hepatitis B virus infection.
    Tyagi P; Arora A
    JNMA J Nepal Med Assoc; 2011; 51(182):94-101. PubMed ID: 22916521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Gerlich WH
    Intervirology; 2014; 57(3-4):202-11. PubMed ID: 25034489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare.
    Nguyen V; Tan PK; Greenup AJ; Glass A; Davison S; Samarasinghe D; Holdaway S; Strasser SI; Chatterjee U; Jackson K; Locarnini SA; Levy MT
    Aliment Pharmacol Ther; 2014 May; 39(10):1225-34. PubMed ID: 24666381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.
    Han GR; Jiang HX; Wang CM; Ding Y; Wang GJ; Yue X; Zhou L; Zhao W
    J Viral Hepat; 2017 Jun; 24(6):514-521. PubMed ID: 28039902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antiviral treatment for pregnant women with chronic HBV infection].
    Xie Y; Li MH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):486-7. PubMed ID: 20678434
    [No Abstract]   [Full Text] [Related]  

  • 51. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
    He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
    Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful pregnancy outcome in decompensated chronic liver disease with portal vein thrombosis: case report and review of literature.
    Kumar M; Kamani L; Hussain R; Siddique S
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):617-9. PubMed ID: 21593679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of chronic hepatitis B in pregnancy.
    Buchanan C; Tran TT
    Clin Liver Dis; 2010 Aug; 14(3):495-504. PubMed ID: 20638027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.
    Mak LY; Seto WK; Lai CL; Yuen MF
    Expert Opin Drug Saf; 2016; 15(3):383-92. PubMed ID: 26752687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.
    Chamroonkul N; Piratvisuth T
    Paediatr Drugs; 2017 Jun; 19(3):173-181. PubMed ID: 28434087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic hepatitis B infection in pregnancy illustrated by a case of successful treatment with entecavir.
    Kakogawa J; Sakurabashi A; Sadatsuki M; Gomibuchi H; Minoura S
    Arch Gynecol Obstet; 2011 Dec; 284(6):1595-6. PubMed ID: 21861151
    [No Abstract]   [Full Text] [Related]  

  • 57. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
    Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW; Chen YG
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mother-to-infant transmission of hepatitis B virus: challenges and perspectives.
    Shih YF; Liu CJ
    Hepatol Int; 2017 Nov; 11(6):481-484. PubMed ID: 29064028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.